BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Money on the Move: Biotechs Target Cancers, Dermatology and Strokes

  Private investors, governmental institutions and longtime life sciences investors provided funding to develop therapies for cancers, dermatological problems and acute ischemic strokes.

  May 25, 2022

   · 

  4 min read

   · 

  Hannah Chudleigh
• 

  Policy

  Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

  Concerns are mounting for people that have been given Pfizer’s Paxlovid treatment regimen after contracting COVID-19, only to become positive for the infection once again.

  May 25, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Chemspace Reopens Kyiv Office to Supply Chemicals to Life Sciences Industry

  Three months after the invasion began, Yurii Moroz, the executive director of Kyiv-based Chemspace LLC, has returned to his offices to restart operations.

  May 25, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Global Roundup: Iceland’s Alvotech Hits Mark with Biosimilar to Janssen’s Stelara

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  May 25, 2022

   · 

  7 min read

   · 

  Alex Keown
• 

  Job Trends

  $2.1B Eli Lilly Expansion to Add 500 New Jobs in Indiana

  When the two new sites are up and running, Eli Lilly predicted the project will create up to 500 new jobs - with the expectation of four indirect jobs for each full-time position, based on industry data.

  May 25, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Two Remarkable Women of Takeda’s C-Suite Make the Professional Personal

  At the start of Takeda’s fiscal year on April 1, Ramona Sequeira and Julie Kim stepped into new positions on the company’s executive leadership team and became role models for women.

  May 25, 2022

   · 

  9 min read

   · 

  Abbey Glasure
• 

  Drug Development

  Invectys is Pioneering HLA-G Immune Checkpoint Inhibitors in Cancer Therapeutics

  Invectys is one of only a few companies investigating HLA-G, a natural immune checkpoint inhibitor, for solid tumors.

  May 25, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Moderna and Pfizer: Lawsuits and Charitable Giving on the Agenda

  Monday, Moderna told a Delaware federal court that it was immune from patent-infringement charges over the COVID-19 vaccine because it supplied the vaccine for a U.S. government effort.

  May 25, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Lawsuits Galore: J&J, BMS, GSK, Mylan and Others

  Johnson & Johnson and Momenta Pharmaceuticals have filed a patent infringement lawsuit over a generic multiple sclerosis drug developed by India-based Natco, Gland Pharma and Mylan.

  May 25, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  United Therapeutics Gets FDA Green Light For First Inhaled Hypertension Therapeutic

  Tyvaso DPI marks the first approval of a dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

  May 25, 2022

   · 

  2 min read

   · 

  Hayley Shasteen